Terms: = Sarcomas AND ER, estrogen receptor AND Clinical Outcome
4 results:
1. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
2. Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases.
Domínguez-Malagón HR; González-Conde E; Cano-Valdez AM; Luna-Ortiz K; Mosqueda-Taylor A
Med Oral Patol Oral Cir Bucal; 2014 Jan; 19(1):e44-8. PubMed ID: 24121902
[TBL] [Abstract] [Full Text] [Related]
3. estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Simoni A; Taddei A; Taddei GL
J Chemother; 2003 Dec; 15(6):596-602. PubMed ID: 14998087
[TBL] [Abstract] [Full Text] [Related]
4. Low-grade endometrial stromal sarcoma: hormonal aspects.
Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
[TBL] [Abstract] [Full Text] [Related]
